Cavendish Impact Capital

Massive Bio, is an Artificial Intelligence (AI) powered platform that connects cancer patients and their treating oncologists to clinical trials while enabling pharmaceutical companies to get access to patients, mostly in community practices, and their information to speed up drug development. Massive Bio combines technology, services and oncology sub-specialist expertise to maximize trial enrollment. Massive Bio is the first company that attacks controlling patient enrollment value chain; Massive Bio does patient identification through direct direct and indirect patient acquisition channels, pre-screening through virtual site, Just-In-Time (JIT) site activation and further analyzes real world data for drug discovery. One of the major differentiating point of Massive Bio is that the Company tackles “last mile” issues for trial enrollment to eliminate site and/or financial considerations of patients. Massive Bio is the go to partner for pharmaceutical companies and CROs to get the right patient at the right time.

Sandstone Diagnostics offers a centrifuge system that provides plasma and serum collection at-home and the point-of-care. It specializes in the fields of clinical diagnostics, home healthcare, and fertility. It was founded in 2012 and headquartered in Pleasanton, California.

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

Turner Imaging Systems, Inc., founded in 2016 and based in Orem, Utah, specializes in the development, manufacturing, and marketing of innovative x-ray imaging systems. The company's flagship product, the Smart-C Mini-C Arm, is a battery-powered, portable fluoroscopy and x-ray imaging device designed to enhance accessibility and usability in various medical settings. This hand-transportable system allows healthcare professionals to acquire x-ray images conveniently, thereby improving the efficiency of fluoroscopy procedures. Turner Imaging Systems aims to expand the reach of x-ray imaging technology, particularly in underserved areas and humanitarian efforts globally.

Turner Imaging Systems, Inc., founded in 2016 and based in Orem, Utah, specializes in the development, manufacturing, and marketing of innovative x-ray imaging systems. The company's flagship product, the Smart-C Mini-C Arm, is a battery-powered, portable fluoroscopy and x-ray imaging device designed to enhance accessibility and usability in various medical settings. This hand-transportable system allows healthcare professionals to acquire x-ray images conveniently, thereby improving the efficiency of fluoroscopy procedures. Turner Imaging Systems aims to expand the reach of x-ray imaging technology, particularly in underserved areas and humanitarian efforts globally.

Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.